Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: FIBROBLAST GROWTH FACTORS - BLOOD , . Treffer: 12

2019

Al-Dury, S; Wahlström, A; Panzitt, K; Thorell, A; Ståhlman, M; Trauner, M; Fickert, P; Bäckhed, F; Fändriks, L; Wagner, M; Marschall, HU Obeticholic acid may increase the risk of gallstone formation in susceptible patients.
J Hepatol. 2019; 71(5):986-991 Doi: 10.1016/j.jhep.2019.06.011
Web of Science PubMed FullText FullText_MUG

 

2018

Mhatre, KN; Wakula, P; Klein, O; Bisping, E; Völkl, J; Pieske, B; Heinzel, FR Crosstalk between FGF23- and angiotensin II-mediated Ca²⁺ signaling in pathological cardiac hypertrophy.
Cell Mol Life Sci. 2018; 75(23):4403-4416 Doi: 10.1007/s00018-018-2885-x
Web of Science PubMed FullText FullText_MUG

 

2016

Verheyen, N; Fahrleitner-Pammer, A; Pieske, B; Meinitzer, A; Belyavskiy, E; Wetzel, J; Gaksch, M; Grübler, MR; Catena, C; Sechi, LA; Van, Ballegooijen, AJ; Brandenburg, VM; Scharnagl, H; Perl, S; Brussee, H; März, W; Pilz, S; Tomaschitz, A Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
J Hypertens. 2016; 34(9):1778-86 Doi: 10.1097/HJH.0000000000001004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zittermann, A; Ernst, JB; Pilz, S; Dreier, J; Kuhn, J; Knabbe, C; Gummert, JF; Morshuis, M; Milting, H Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device.
PLoS One. 2016; 11(10):e0164459-e0164459 Doi: 10.1371/journal.pone.0164459 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zittermann, A; Morshuis, M; Kuhn, J; Pilz, S; Ernst, JB; Oezpeker, C; Dreier, J; Knabbe, C; Gummert, JF; Milting, H Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk.
Eur J Nutr. 2016; 55(1):305-313 Doi: 10.1007/s00394-015-0847-8
Web of Science PubMed FullText FullText_MUG

 

2015

Brandenburg, VM; Kleber, ME; Vervloet, MG; Larsson, TE; Tomaschitz, A; Pilz, S; Stojakovic, T; Delgado, G; Grammer, TB; Marx, N; März, W; Scharnagl, H Soluble klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Atherosclerosis. 2015; 242(2):483-489 Doi: 10.1016/j.atherosclerosis.2015.08.017
Web of Science PubMed FullText FullText_MUG

 

Koller, L; Kleber, ME; Brandenburg, VM; Goliasch, G; Richter, B; Sulzgruber, P; Scharnagl, H; Silbernagel, G; Grammer, TB; Delgado, G; Tomaschitz, A; Pilz, S; Berger, R; Mörtl, D; Hülsmann, M; Pacher, R; März, W; Niessner, A Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.
Circ Heart Fail. 2015; 8(6):1059-1067 Doi: 10.1161/CIRCHEARTFAILURE.115.002341 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Reinehr, T; Karges, B; Meissner, T; Wiegand, S; Fritsch, M; Holl, RW; Woelfle, J Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
J Clin Endocrinol Metab. 2015; 100(8): 3004-3010. Doi: 10.1210/jc.2015-2192 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schnedl, C; Fahrleitner-Pammer, A; Pietschmann, P; Amrein, K FGF23 in Acute and Chronic Illness.
Dis Markers. 2015; 2015(12):358086-358086 Doi: 10.1155/2015/358086 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schneider, A; Schneider, MP; Krieter, DH; Genser, B; Scharnagl, H; Stojakovic, T; Wanner, C; Drechsler, C Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial.
PLoS One. 2015; 10(5):e0128079-e0128079 Doi: 10.1371/journal.pone.0128079 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Brandenburg, VM; Kleber, ME; Vervloet, MG; Tomaschitz, A; Pilz, S; Stojakovic, T; Delgado, G; Grammer, TB; Marx, N; März, W; Scharnagl, H Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Atherosclerosis. 2014; 237(1):53-59 Doi: 10.1016/j.atherosclerosis.2014.08.037
Web of Science PubMed FullText FullText_MUG

 

2009

Nawrot-Wawrzyniak, K; Varga, F; Nader, A; Roschger, P; Sieghart, S; Zwettler, E; Roetzer, KM; Lang, S; Weinkamer, R; Klaushofer, K; Fratzl-Zelman, N Effects of tumor-induced osteomalacia on the bone mineralization process.
Calcif Tissue Int. 2009; 84(4): 313-323. Doi: 10.1007/s00223-009-9216-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum